← All organizations

Vir Biotechnology, Inc.

For profitWebsite ↗

Also known as: Vir Biotechnology, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 5, 2025

Timeline

2010s

Jun 1, 2016
Vir Biotechnology, Inc.— Founded

Drugs by trial phase (21 distinct, 31 trials)

Phase 3 (8 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (31)

NCT05235347Lead sponsorN/A—
NCT07142811Lead sponsorPhase 2Aug 5, 2025
NCT07128550Lead sponsorPhase 3Jul 30, 2025
NCT06960395Lead sponsorPhase 1Jul 22, 2025
NCT06903338Lead sponsorPhase 3Mar 12, 2025
NCT06491563CollaboratorPhase 2Aug 31, 2024
NCT05854381Lead sponsorPhase 1Sep 19, 2023
NCT05970289CollaboratorPhase 2Aug 22, 2023
NCT05844228Lead sponsorPhase 1Jun 1, 2023
NCT05612581Lead sponsorPhase 1/Phase 2Nov 9, 2022
NCT05567783Lead sponsorPhase 2Oct 30, 2022
NCT05484206Lead sponsorPhase 1Sep 21, 2022
NCT05461170Lead sponsorPhase 2Sep 17, 2022
NCT05135650CollaboratorPhase 1May 1, 2022
NCT05280717Lead sponsorPhase 1Mar 28, 2022

Details

Founded: San Francisco, CA, US Jun 1, 2016
Last known activity: Aug 5, 2025